Pharmacosmos A/S, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, and G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company focused on delivering next-generation therapies that improve the lives of those affected by cancer, announce that Pharmacosmos A/S has successfully completed the previously announced tender offer to acquire all outstanding shares of G1 Therapeutics for U.S. $7.15 per share net to the holder in cash, without interest and less any applicable withholding taxes (the “Offer Price”), for a total equity value of approximately $405 million.
Read the full article: Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer //
Source: https://www.globenewswire.com/news-release/2024/09/18/2948213/0/en/Pharmacosmos-Group-and-G1-Therapeutics-Announce-Successful-Closing-of-Tender-Offer.html